International Homeopathic Medical League LMHI

Homeopathic drug proving is essential in the development of the homeopathic art of cure. After clinical verification of the collected symptoms, it provides a necessary tool to find the most appropriate remedy for the patient.

Systematic clinical data collection must match contemporary reality as a whole. The aim of these guidelines is to promote convergence in the publications on verification of homeopathic symptoms.

Revised edition after 67th LMHI Congress, September 2012 (Nara, Japan)

This joint production of the Liga Medicorum Homeopathica Internationalis (LMHI) and the European Committee for Homeopathy (ECH) is aimed at considering all important aspects of the scientific framework of homeopathic practice including ethical questions, evaluation of daily practice, looking at the level of scientific evidence of each of these aspects. In conclusion, homeopathy has to stay in the framework of medical practice and it is a necessity for public health - but there is also the need for more research.

This LMHI Research Working Group report has been requested by the LMHI's National Vice-President for Belgium, Dr. Léon Scheepers. He asked for scientific advice about an official Belgian report published by the Federal Health Care Knowledge Centre (KCE) on 24 May 2011. The Belgian homeopathic association Unio Homeopathica Belgica (UHB) expresses some doubts about the scientific relevancy of certain parts of the KCE report, especially the part evaluating clinical efficacy concluding that "no convincing proof of efficacy exists for any condition for which a systematic review was available". The Research Working Group (RWG) agreed to scrutinize and comment on this report using the normal scientific perspective for evaluation of efficacy in medicine.